Treatment of hyperkalemia in a patient with unrecognized digitalis toxicity

Area of Science:

• Cardiology
• Toxicology
• Nephrology

Background:

• Cardiac glycoside toxicity commonly presents with hyperkalemia and dysrhythmias, particularly in patients with renal insufficiency.
• Intravenous calcium and transvenous cardiac pacing are typically contraindicated in cardiac glycoside toxicity.
• These interventions are often considered high-risk due to potential for exacerbating toxicity.

Observation:

• A patient with acute renal failure presented with severe bradydysrhythmia and hyperkalemia.
• The patient received intravenous calcium and transvenous cardiac pacing.
• No adverse events were observed during or after the administration of these therapies.

Findings:

• The patient was later diagnosed with digitalis toxicity.
• Digoxin-specific antibody fragments and hemodialysis were administered as definitive treatments.
• The use of calcium and cardiac pacing did not lead to adverse outcomes in this case.

Implications:

• This case suggests that calcium and cardiac pacing may be safely utilized in select patients with cardiac glycoside toxicity and associated complications.
• The findings challenge the absolute contraindication of these therapies in specific clinical scenarios.
• Further research is warranted to delineate the precise role and safety profile of calcium and pacing in managing cardiac glycoside toxicity.